Kiener; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kiener; Peter.The latest application filed is for "humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease".

Company Profile

4.17.49

Kiener; Peter - Potomac MD
KIENER; PETER - GAITHERSURG MD
Kiener; Peter - Doylestown PA
Kiener, Peter - Doylestwon PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20210061906 - Damschroder; Melissa ; et al.	2021-03-04
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20200172625 - COYLE; ANTHONY ; et al.	2020-06-04
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20200055944 - Coyle; Anthony ; et al.	2020-02-20
Multivalent and monovalent multispecific complexes and their uses Grant 10,526,381 - Roschke , et al. J	2020-01-07
Anti-IFNAR1 antibodies with reduced Fc ligand affinity Grant 10,301,390 - Coyle , et al.	2019-05-28
EGFR-binding modular recognition domains Grant 10,150,800 - Roschke , et al. Dec	2018-12-11
Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides Grant 10,087,222 - Roschke , et al. October 2, 2	2018-10-02
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20180273621 - Damschroder; Melissa ; et al.	2018-09-27
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20180244791 - Coyle; Anthony ; et al.	2018-08-30
Anti-IFNAR1 antibodies with reduced Fc ligand affinity Grant 9,988,459 - Coyle , et al. June 5, 2	2018-06-05
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20180118839 - COYLE; ANTHONY ; et al.	2018-05-03
Ang-2 Binding Modular Recognition Domain Complexes and Pharmaceutical Compositions Thereof App 20180072783 - ROSCHKE; Viktor ; et al.	2018-03-15
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 9,896,505 - Damschroder , et al. February 20, 2	2018-02-20
Multivalent and Monovalent Multispecific Complexes and Their Uses App 20170298106 - ROSCHKE; Viktor ; et al.	2017-10-19
Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof Grant 9,676,833 - Roschke , et al. June 13, 2	2017-06-13
Interferon Alpha-induced Pharmacodynamic Markers And Uses Thereof App 20170121771 - YAO; YIHONG ; et al.	2017-05-04
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20170101468 - Bowen; Michael ; et al.	2017-04-13
Ang-2 Binding Complexes and Uses Thereof App 20160176934 - ROSCHKE; Viktor ; et al.	2016-06-23
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20160145335 - Damschroder; Melissa ; et al.	2016-05-26
Multivalent And Monovalent Multispecific Complexes And Their Uses App 20160046678 - ROSCHKE; Viktor ; et al.	2016-02-18
Multivalent and Monovalent Multispecific Complexes and Their Uses App 20150210765 - ROSCHKE; VIKTOR ; et al.	2015-07-30
Interferon Alpha-induced Pharmacodynamic Markers And Uses Thereof App 20150147336 - YAO; Yihong ; et al.	2015-05-28
Interferon Alpha-induced Pharmacodynamic Markers App 20150132313 - YAO; Yihong ; et al.	2015-05-14
Interferon Alpha-induced Pharmacodynamic Markers And Uses Thereof App 20150044222 - YAO; Yihong ; et al.	2015-02-12
Humanized anti-CD19 antibodies Grant 8,883,992 - Damschroder , et al. November 11, 2	2014-11-11
Human Anti Il-6 Antibodies With Extended In Vivo Half-life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases App 20140302058 - Bowen; Michael ; et al.	2014-10-09
Multivalent and Monovalent Multispecific Complexes and Their Uses App 20140065142 - ROSCHKE; Viktor ; et al.	2014-03-06
Ang-2 Binding Complexes and Uses Thereof App 20130259868 - ROSCHKE; Viktor ; et al.	2013-10-03
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20130115657 - Damschroder; Melissa ; et al.	2013-05-09
Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells Grant 8,404,236 - Wu , et al. March 26, 2	2013-03-26
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Grant 8,323,653 - Damschroder , et al. December 4, 2	2012-12-04
Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells App 20120141463 - Wu; Herren ; et al.	2012-06-07
Ang-2 Binding Complexes and Uses Thereof App 20120100166 - Roschke; Viktor ; et al.	2012-04-26
High affinity antibodies against HMGB1 and methods of use thereof Grant 8,153,131 - Wu , et al. April 10, 2	2012-04-10
Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells Grant 8,137,670 - Wu , et al. March 20, 2	2012-03-20
High affinity antibodies against HMGB1 and methods of use thereof Grant 8,129,130 - Wu , et al. March 6, 2	2012-03-06
Interferon Alpha-induced Pharmacodynamic Markers App 20110287022 - Yao; Yihong ; et al.	2011-11-24
High Affinity Antibodies Against HMGB1 and Methods of Use Thereof App 20110287023 - Wu; Herren ; et al.	2011-11-24
Immunogenic Compositions Comprising Hmgb1 Polypeptides App 20110236406 - Messmer; Davorka ; et al.	2011-09-29
High affinity antibodies against HMGB1 and methods of use thereof Grant 7,964,706 - Wu , et al. June 21, 2	2011-06-21
Anti-ifnar1 Antibodies With Reduced Fc Ligand Affinity App 20110059078 - Coyle; Anthony ; et al.	2011-03-10
Methods of Treating RSV Infections And Related Conditions App 20110008329 - Krishnan; Subramaniam ; et al.	2011-01-13
Epha2 Monoclonal Antibodies And Methods Of Use Thereof App 20100278838 - Kinch; Michael S. ; et al.	2010-11-04
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies App 20100278813 - Young; James F. ; et al.	2010-11-04
Interferon Alpha-induced Pharmacodynamic Markers App 20100261172 - Yao; Yihong ; et al.	2010-10-14
Interferon Alpha-induced Pharmacodynamic Markers App 20100143372 - Yao; Yihong ; et al.	2010-06-10
Compounds And Methods For Treating Or Preventing Autoimmune Diseases App 20100093611 - Horrigan; Stephen K. ; et al.	2010-04-15
High Affinity Antibodies Against HMGB1 and Methods Of Use Thereof App 20100061987 - Wu; Herren ; et al.	2010-03-11
Molecules with extended half-lives, compositions and uses thereof Grant 7,658,921 - Dall'Acqua , et al. February 9, 2	2010-02-09
High affinity antibodies against HMGB1 and methods of use thereof Grant 7,585,504 - Wu , et al. September 8, 2	2009-09-08
High Affinity Antibodies Against Hmgb1 And Methods Of Use Thereof App 20090169546 - Wu; Herren ; et al.	2009-07-02
Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents App 20090148459 - Woessner; Richard ; et al.	2009-06-11
Method of Identifying Membrane Ig Specific Antibodies and Use Thereof for Targeting Immunoglobulin-Producing Precursor Cells App 20090130111 - Wu; Herren ; et al.	2009-05-21
Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof App 20080311122 - Wu; Herren ; et al.	2008-12-18
Immunogenic Compositions Comprising Hmgb 1 Polypeptides App 20080305120 - Messmer; Davorka ; et al.	2008-12-11
Molecules with extended half-lives, compositions and uses thereof App 20080181887 - Dall-Acqua; William ; et al.	2008-07-31
Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease App 20080138336 - Damschroder; Melissa ; et al.	2008-06-12
EpA2 monoclonal antibodies and methods of use thereof App 20070166314 - Kinch; Michael S. ; et al.	2007-07-19
High affinity antibodies against HMGB1 and methods of use thereof App 20060099207 - Wu; Herren ; et al.	2006-05-11
PCDGF receptor antibodies and methods of use thereof App 20050175616 - Kiener, Peter ; et al.	2005-08-11
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies App 20040096451 - Young, James F. ; et al.	2004-05-20
EphA2 monoclonal antibodies and methods of use thereof App 20040028685 - Kinch, Michael S. ; et al.	2004-02-12
Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents App 20040001835 - Woessner, Richard ; et al.	2004-01-01
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases App 20020119972 - Leftheris, Katerina ; et al.	2002-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.